Intellect Neurosciences, Inc.: 10-Q filed 2014-11-14

Name: Intellect Neurosciences, Inc.: 10-Q filed 2014-11-14
Creator: Intellect Neurosciences, Inc.

What Intellect Neurosciences, Inc. reported in its quarterly report filed 2014-11-14 (fiscal Q1 2015): 18 published measures, 38 facts as tagged in accession 0001615774-14-000308.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-11-14
Fiscal period: fiscal Q1 2015
Accession: 0001615774-14-000308 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Intellect Neurosciences, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-09-30	403,546	USD
At 2014-06-30	2,250	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-09-30	23,999,629	USD
At 2014-06-30	28,163,041	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2014-09-30	-23,596,083	USD
At 2014-06-30	-28,160,791	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-09-30	401,296	USD
At 2014-06-30	0	USD
At 2013-09-30	20,286	USD
At 2013-06-30	5,138	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	3,374,097	USD	92
2013-07-01 to 2013-09-30	-4,097,019	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-09-30	-95,578,803	USD
At 2014-06-30	-98,943,510	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	-495,367	USD	92
2013-07-01 to 2013-09-30	-366,602	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-09-30	401,296	USD
At 2014-06-30	0	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	1,726,795	USD	92
2013-07-01 to 2013-09-30	3,736,878	USD	92

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2014-09-30	23,015,374	USD
At 2014-06-30	27,435,838	USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	27,326	USD	92
2013-07-01 to 2013-09-30	9,479	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2014-09-30	623,512,076	shares
At 2014-06-30	409,512,076	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2014-09-30	71,359,098	USD
At 2014-06-30	70,373,087	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	3,374,097	USD	92
2013-07-01 to 2013-09-30	-4,097,019	USD	92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	468,041	USD	92
2013-07-01 to 2013-09-30	357,123	USD	92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	3,869,464	USD	92
2013-07-01 to 2013-09-30	-3,730,417	USD	92

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	0	USD	92
2013-07-01 to 2013-09-30	0	USD	92

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2014-07-01 to 2014-09-30	0	USD	92
2013-07-01 to 2013-09-30	0	USD	92

Inspect the source

Entity: Intellect Neurosciences, Inc. / CIK 0001337905
Captured: 2026-09-23 02:49 UTC
SEC response SHA-256: 236c93f4b109a1d0e3c5b32c838cb7ed4bcea14b1d8d77aad2aa400fa8dd42ce

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001337905.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))